Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential
Autor: | Lalit Khurana, Rishi Kapil, Shantanu Bandyopadhyay, Bhupinder Singh, Om Prakash Katare |
---|---|
Rok vydání: | 2011 |
Předmět: |
Glycerol
Male Materials science Central composite design Chemistry Pharmaceutical Carbazoles Biological Availability Pharmaceutical Science Intestinal absorption Glycerides Excipients Propanolamines Drug Delivery Systems Drug Stability Microscopy Electron Transmission Pulmonary surfactant Animals Particle Size Rats Wistar Solubility Chromatography Cardiovascular Agents General Medicine Nanostructures Rats Bioavailability Perfusion Jejunum Intestinal Absorption Drug delivery Cardiovascular agent Carvedilol Emulsions Ethylene Glycols Particle size Caprylates Oils |
Zdroj: | Drug Delivery. 18:599-612 |
ISSN: | 1521-0464 1071-7544 |
DOI: | 10.3109/10717544.2011.604686 |
Popis: | Carvedilol, a widely prescribed cardiovascular drug for hypertension and congestive heart failure, exhibits low and variable bioavailability owing to poor absorption and extensive hepatic first-pass metabolism. The current research work, therefore, entails formulation development of liquid self-nano-emulsifying drug delivery systems (SNEDDS) to enhance the bioavailability of carvedilol by facilitating its transport via lymphatic circulation. The formulation constituents, i.e. lipids, surfactants, and co-surfactants, were selected on the basis of solubility studies. Pseudo-ternary phase diagrams were constructed to embark upon the selection of blend of lipidic (i.e. Capmul PG8) and hydrophilic components (i.e. Cremophor EL as surfactant and Transcutol HP as co-surfactant) for efficient and robust formulation of SNEDDS. The SNEDDS, systematically optimized employing a central composite design (CCD), were evaluated for various response variables viz drug release parameters, emulsification time, emulsion droplet size, and mean dissolution time. In vitro drug release studies depicted that the release from SNEDDS systems followed a non-Fickian kinetic behavior. The TEM imaging of the optimized formulation affirmed the uniform shape and nano size of the system. Accelerated studies of the optimized formulation indicated high stability of the formulation for 6 months. The in situ perfusion studies carried out in wistar rats construed several fold augmentation in the permeability and absorption potential of the optimized formulation vis-à-vis marketed formulation. Thus, the present studies ratified the potential of SNEDDS in augmenting the oral bioavailability of BCS class II drugs. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |